Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Dynavision Ltd

DYNAVSN
BSE
179.80
2.20%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Dynavision Ltd

DYNAVSN
BSE
179.80
2.20%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
69Cr
Close
Close Price
179.80
Industry
Industry
Miscellaneous
PE
Price To Earnings
13.86
PS
Price To Sales
5.12
Revenue
Revenue
13Cr
Rev Gr TTM
Revenue Growth TTM
2.51%
PAT Gr TTM
PAT Growth TTM
-9.49%
Peer Comparison
How does DYNAVSN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
DYNAVSN
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
222333333333
Growth YoY
Revenue Growth YoY%
10.514.034.777.255.050.021.90.31.53.64.7
Expenses
ExpensesCr
100111111111
Operating Profit
Operating ProfitCr
122233223323
OPM
OPM%
68.980.178.278.184.284.169.174.884.381.359.676.2
Other Income
Other IncomeCr
010101000111
Interest Expense
Interest ExpenseCr
000011111111
Depreciation
DepreciationCr
000011111111
PBT
PBTCr
122222112212
Tax
TaxCr
000100101111
PAT
PATCr
122222111211
Growth YoY
PAT Growth YoY%
36.31.330.870.17.1-36.4-33.8-35.1-8.8-10.230.8
NPM
NPM%
50.380.170.060.448.355.429.732.831.249.725.741.0
EPS
EPS
2.54.44.14.14.34.82.62.72.74.32.33.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
8101313
Growth
Revenue Growth%
34.127.42.4
Expenses
ExpensesCr
2233
Operating Profit
Operating ProfitCr
681010
OPM
OPM%
78.380.578.375.3
Other Income
Other IncomeCr
1222
Interest Expense
Interest ExpenseCr
0132
Depreciation
DepreciationCr
0122
PBT
PBTCr
6878
Tax
TaxCr
2223
PAT
PATCr
5655
Growth
PAT Growth%
30.6-24.11.3
NPM
NPM%
64.162.437.236.8
EPS
EPS
12.917.012.813.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
4444
Reserves
ReservesCr
8141922
Current Liabilities
Current LiabilitiesCr
3576
Non Current Liabilities
Non Current LiabilitiesCr
20424039
Total Liabilities
Total LiabilitiesCr
34687274
Current Assets
Current AssetsCr
22233234
Non Current Assets
Non Current AssetsCr
12454140
Total Assets
Total AssetsCr
34687274

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-11110
Investing Cash Flow
Investing Cash FlowCr
2-38-4
Financing Cash Flow
Financing Cash FlowCr
026-4
Net Cash Flow
Net Cash FlowCr
101
Free Cash Flow
Free Cash FlowCr
-3-217
CFO To PAT
CFO To PAT%
-23.5174.2199.3
CFO To EBITDA
CFO To EBITDA%
-19.3135.094.7

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
50107103
Price To Earnings
Price To Earnings
10.116.420.9
Price To Sales
Price To Sales
6.510.37.8
Price To Book
Price To Book
4.35.94.5
EV To EBITDA
EV To EBITDA
5.913.410.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0
OPM
OPM%
78.380.578.3
NPM
NPM%
64.162.437.2
ROCE
ROCE%
59.422.822.2
ROE
ROE%
42.835.721.3
ROA
ROA%
14.59.56.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
**Dynavision Limited**, established in **1973**, is an Indian enterprise currently undergoing a strategic metamorphosis. Originally a household name in consumer electronics through its **DYANORA** brand, the company has successfully pivoted into a diversified holding structure. Today, its business model is anchored by high-yield **Asset Leasing** and a rapidly expanding **Renewable Energy** portfolio, with emerging interests in the **Med-Tech** manufacturing sector. --- ### **Core Business Segments & Revenue Architecture** Dynavision operates through a dual-segment structure designed to balance steady cash flows with high-growth infrastructure projects. | Segment | Primary Activity | Key Assets & Strategic Value | |:---|:---|:---| | **Renting of Investment Property** | Long-term leasing of premium land and industrial premises. | **2.63 acres** in Chennai leased to **Apollo Hospitals Enterprise Ltd (AHEL)** on a **29-year** term (expiring 2041). | | **Solar Power & EPC Services** | Solar power generation and Engineering, Procurement, and Commissioning (EPC). | Operates a **6 MW AC** solar plant in **Tamil Nadu**; provides end-to-end EPC services for captive power projects. | #### **1. Real Estate & Lease Rental Portfolio** The company’s foundational revenue stream is derived from its significant real estate holdings. * **Lease Income:** Generated **Rs. 8.82 crore** in FY25, up from **Rs. 8.71 crore** the previous year. * **Asset Valuation:** As of March 31, 2025, the investment property carries a book value of **Rs. 6.07 crore**, while its **Fair Value** is estimated at a substantial **Rs. 56.70 crore**. * **Future Receivables:** The company has secured long-term visibility with total undiscounted future minimum lease receivables calculated at **Rs. 206.62 crore** (as of March 2023). #### **2. Renewable Energy Expansion (Dynavision Green Solutions Limited)** The company executes its green energy strategy through its wholly-owned subsidiary, incorporated in **September 2022**. * **The Captive Model:** A tripartite agreement exists between Dynavision, its subsidiary, and **Apollo Hospitals** (the captive user), ensuring a guaranteed off-take for generated power. * **Project Milestones:** * **6 MW AC Aruppukottai Project:** Completed with an EPC contract value of **Rs. 31.80 crore**; commercial production began in **November 2023**. * **Capacity Addition:** An additional **477 KW** expansion was completed in **July 2024**. * **Regional Advantage:** Operations are concentrated in **Tamil Nadu**, which targets **25,000 MW** of solar capacity by **2030** and offers high solar resource potential (**5,600 Wh/m²/day**). --- ### **Financial Performance & Capital Structure** Dynavision maintains a conservative, **zero-debt** balance sheet, funding its capital-intensive transitions primarily through internal accruals and strategic asset liquidation. #### **Comparative Financial Summary** | Metric (Standalone) | FY 2024-25 (₹ Cr) | FY 2023-24 (₹ Cr) | FY 2022-23 (₹ Cr) | | :--- | :--- | :--- | :--- | | **Total Income** | **12.13** | **39.88** | **8.78** | | **Profit After Tax (PAT)** | **6.20** | **7.38** | **5.26** | | **Consolidated Income** | **15.09** | **12.34** | **8.78** | | **Consolidated PAT** | **4.90** | **6.46** | **5.26** | * **Net Worth Growth:** Increased significantly to **Rs. 19.25 crore** (March 2024) from **Rs. 11.87 crore** the prior year. * **Equity Base:** The paid-up equity share capital remains stable at **Rs. 3.84 crore**. * **Inter-company Support:** The parent company provides financial scaffolding to its subsidiary, with an outstanding loan of **Rs. 1.65 crore** and authorized investment limits in subsidiary debt instruments up to **Rs. 15.00 crore**. --- ### **Strategic Pivot: Asset Monetization & Med-Tech Entry** The management is currently executing a "Capital Recycling" strategy—liquidating non-core or mature assets to fund high-growth frontiers. * **Asset Divestment:** In 2024, the Board approved the sale of land at **Kottivakkam** (currently leased to AHEL) and **two commercial spaces** in Chennai to mobilize liquidity. * **Healthcare Diversification:** Leveraging its relationship with the healthcare sector, Dynavision is exploring **Medical Device Manufacturing**. * **Market Intelligence:** Appointed **IPSOS Research Private Limited** in **December 2023** to identify high-potential healthcare products. * **Regulatory Tailwinds:** The move aims to capitalize on Indian government mandates for **minimum local content** in medical procurement. * **Resource Mobilization:** To support these ventures, the company has enhanced its Section 186 investment limits to **Rs. 100 crore** and is exploring **preferential issues** of equity or convertible warrants. --- ### **Risk Profile & Mitigation Framework** Dynavision operates in sectors characterized by high regulatory oversight and capital intensity. #### **Operational & Sectoral Challenges** * **Infrastructure & Supply Chain:** A lack of domestic R&D for solar components (panels/inverters) creates **import dependency**. Solar generation is also subject to **intermittency** and technical risks like **GNSS signal** reliance for grid synchronization. * **Power Sector Dynamics:** While there is a national power deficit of **8-10%**, the sector involves complex state-level payment guarantees and regulatory hurdles. * **Human Capital:** The company operates with a very lean team of **8 employees**, necessitating efficient outsourced management and strong internal controls. #### **Financial Risk Management** The **Audit Committee** oversees a structured risk mitigation framework: * **Credit Risk:** Surplus cash is strictly deployed in banks or mutual funds with **high external credit ratings**. * **Liquidity Risk:** Managed through rolling liquidity forecasts and monitoring **Balance Sheet liquidity ratios** to ensure maturity profiles of assets match liabilities. * **Governance Exemptions:** Due to its size (Paid-up capital < **Rs. 10 Cr**; Net Worth < **Rs. 25 Cr**), the company is exempt from certain **SEBI (LODR)** disclosures, though it maintains a voluntary **Risk Management Policy** and **POSH** compliance via the Audit Committee. --- ### **Investment Outlook** Dynavision Limited represents a unique "transformation play." By transitioning from a passive landlord to an active **Solar EPC player** and prospective **Med-Tech manufacturer**, the company is repositioning itself for the next decade of India’s industrial growth. Investors should monitor the successful deployment of capital from recent asset sales into the new healthcare and renewable energy initiatives.